Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-7drxs Total loading time: 0 Render date: 2024-07-16T23:51:39.281Z Has data issue: false hasContentIssue false

61 - Liver tumors and resections

from Part VI - Oncology

Published online by Cambridge University Press:  08 January 2010

By
Jean de Ville de Goyet  and
Jean-Bernard Otte
Edited by
Mark D. Stringer ,
Keith T. Oldham  and
Pierre D. E. Mouriquand
Jean de Ville de Goyet
Affiliation:
Transplant and Paediatric Surgery, St. Luc University Hospital, Brussels, Belgium
Jean-Bernard Otte
Affiliation:
Transplant and Paediatric Surgery, St. Luc University Hospital, Brussels, Belgium
Mark D. Stringer
Affiliation:
University of Otago, New Zealand
Keith T. Oldham
Affiliation:
Children's Hospital of Wisconsin
Pierre D. E. Mouriquand
Affiliation:
Debrousse Hospital, Lyon
Get access

Summary

Short- and long-term outcomes of children with malignancies have improved considerably during the last four decades. According to the review by Ries et al. (1991), the survival rate for cancer cases diagnosed before 15 years of age has improved from around 50% in the early 1970s to 75% a decade later. This favorable trend has been observed not only in hematologic malignancies but also in many solid tumors such as Wilms' tumor and hepatoblastoma. This progress is due to many factors including advances in medical expertise, surgical techniques, and most importantly innovation and refinement of adjuvant chemotherapy. With growing numbers of surviving patients, the long-term side effects of chemotherapy are now viewed with increasing concern and may lead us to reconsider therapeutic strategies in the future, possibly promoting further integration of genetic and tumor markers into tailored management protocols.

Children with cancers represent a unique population for studying genetic and environmental mechanisms of cancer etiology, and also genetic factors or tumor markers associated with survival. Identifying mechanisms and/or markers encourages the development of prevention, screening or pre-emptive treatment strategies. However, less is known about children's cancers compared to adults and additional research is necessary; the relatively small number of children with cancer and the lack of co-ordinated studies has led, for too long, to fragmentation and duplication of research effort. Large collaborative trials in pediatric cancer research are a priority.

Type
Chapter
Information
Pediatric Surgery and Urology
Long-Term Outcomes
 , pp. 799 - 814
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ries, L. A., Hankey, B. F., & Miller, B. A.Cancer Statistics. Review 1973–1988. NIH publication no.91–2789. Bethesda: National Health Institute, 1991.Google Scholar
Shafford, E. A. & Pritchard, J.Hepatoblastoma – a bit of a success story?Eur. J. Cancer 1994; 30A:1050–1051.CrossRefGoogle ScholarPubMed
Stringer, M. D., Hennayake, S., Howard, E. R.et al.Improved outcome for children with hepatoblastoma. Br. J. Surg. 1995; 82:386–391.CrossRefGoogle ScholarPubMed
Perilongo, G., Brown, J., Shafford, E.et al.Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors. Cancer 2000; 89:1845–1853.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Otte, J. B., Aronson, D., Vraux, H.et al.Preoperative chemotherapy major liver resection, and transplantation for primary malignancies in children. Transpl. Proc. 1996; 28:2393–2394.Google ScholarPubMed
Pimpalwar, A. P., Sharif, K., Ramani, P.et al.Strategy for hepatoblastoma management: transplant versus nontransplant surgery. J. Pediatr. Surg. 2002; 37:240–245.CrossRefGoogle ScholarPubMed
Sharif, K., English, M., Ramani, P.et al.Management of hepatic epithelioid hemangioendothelioma in children; what option?Br. J. Cancer 2004; 90:1498–1501.CrossRefGoogle ScholarPubMed
Stocker, J. T. & Ishak, K. G.Mesenchymal hamartoma of the liver: report of 30 cases and review of the literature. Paediatr. Pathol. 1983; 1:215–226.CrossRefGoogle ScholarPubMed
Lauwer, Y. G., Grant, L. D., Dnnelly, W. H.et al.Hepatic Undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am. J. Surg. Pathol. 1997; 21:1248–1254.CrossRefGoogle Scholar
Otal, T. M., Hendricks, J. B., Pharis, P., & Donnelly, W. H.Mesenchymal hamartoma of the liver. Cancer 1994; 74:1237–1242.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
Bove, K. E., Blough, R. I., & Soukup, S.Third report of t(19q)(13.4) in mesenchymal hamartoma of liver with comments on link to embryonal sarcoma. Pediatr. Develop. Pathol. 1998; 1:438–442.CrossRefGoogle Scholar
Chadarevian, J. P., Pawei, B. R., Faeber, E. N.et al.Undifferentiated (embryonal) sarcoma arising in conjuction with mesenchymal hamartoma of the liver. Modern Pathol. 1994; 7:490–494.Google Scholar
O'Sullivan, M. J., Swanson, P. E., Knoll, J., Taboada, E. M., & Dehner, L. P.Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr. Dev. Pathol. 2001; 4:482–489.CrossRefGoogle ScholarPubMed
Corbally, M. & Spitz, L.Malignant potential of mesenchymal hamartoma. An unrecognized risk. Pediatr. Surg. Int. 1992; 7:321–322.CrossRefGoogle Scholar
Ramanujam, T. M., Ramesh, J. C., Goh, D. H.et al.Malignant transformation of mesenchymal hamartoma of the liver. Case report and review of literature. J. Pediatr. Surg. 1999; 34:1684–1686.CrossRefGoogle Scholar
Begueret, H., Trouette, Vielh, P.et al.Hepatic undifferentiated embryonal sarcoma: malignant evolution of mesenchymal hamartoma? Study of one case with immunohistochemical and flow cytometric emphasis. J. Hepatol. 2001; 34:178–179.
Resnick, M. B., Kozakewich, H. P., & Perez-Atayde, A. R.Hepatic adenoma in the pediatric age group. Clinicopathological observations and assessment of cell proliferative activity. Am. J. Surg. Pathol. 1995; 19:1181–1190.CrossRefGoogle ScholarPubMed
Lerut, J. P., Ciccarelli, O., Sempoux, C.et al.Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation. Transpl. Int. 2003; 16:879–884.CrossRefGoogle ScholarPubMed
Leese, T., Farges, O., & Bismuth, H.Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann. Surg. 1988; 208:558–564.CrossRefGoogle ScholarPubMed
Makhlouf, H. R., Ishak, K. G., & Goodman, S. D.Epithelioid hemangioendothelioma of liver. Cancer 1999; 85:562–582.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Uchimura, K., Nakamuta, M., Osoegwa, M.et al.Hepatic epithelioid hemangioendothelioma. J. Clin. Gastroenterol. 2001; 32:431–434.CrossRefGoogle ScholarPubMed
Beers, B., Roche, A., Mathieu, D.et al.Epithelioid hemangioendothelioma of liver. MR and CT finding. J. Comput. Assist. Tomogr. 1992; 16:420–424.CrossRefGoogle Scholar
Clericuzio, C. L., Chen, E., McNeil, D. E.et al.Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith–Wiedemann syndrome or isolated hemihyperplasia. J. Pediatr. 2003; 143:270–272.CrossRefGoogle ScholarPubMed
Thomas, D., Pritchard, J., Davidson, R.et al.Familial hepatoblastoma and APC gene mutations: renewed call for molecular research. Eur. J. Cancer 2003; 39:2200–2204.CrossRefGoogle ScholarPubMed
Pritchard, J., da Cunha, A., Cornbleet, M. A., & Carter, C. J.Alpha feta (alpha FP) monitoring of response to adriamycin in hepatoblastoma. J. Pediatr. Surg. 1982; 17:429–430.CrossRefGoogle ScholarPubMed
Brown, J., Perilongo, G., Shafford, E.et al.Pretreatment prognostic factors for children with hepatoblastoma – results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur. J. Cancer 2000; 36:1418–1425.CrossRefGoogle ScholarPubMed
Hemming, A. W., Langer, B., Sheiner, P., Greig, P. D., & Taylor, B. R.Aggressive surgical management of fibrolamellar hepatocellular carcinoma. J. Gastrointest. Surg. 1997; 1:342–346.CrossRefGoogle ScholarPubMed
Katzenstein, H. M., Krailo, M. D., Malogolowkin, M. H.et al.Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003; 97:2006–2012.CrossRefGoogle ScholarPubMed
Davis, G. L., Kissane, J. M., & Ishak, K. G.Embryonal rhabdomyosarcoma (Sarcoma botryoides) of the biliary tree. Report of five cases and a review of the literature. Cancer 1969; 24:333–342.3.0.CO;2-G>CrossRefGoogle Scholar
Wudel, L. J. Jr., Delbeke, D., Morris, D.et al.The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am. Surg. 2003; 69:117–124.Google Scholar
Ortega, J. A., Douglass, E. C., Feusner, J. H.et al.Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J. Clin. Oncol. 2000; 18:2665–2675.CrossRefGoogle ScholarPubMed
Schweinitz, D., Byrd, D. J., Hecker, H.et al.Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur. J. Cancer 1997; 33:1243–1249.CrossRefGoogle Scholar
Kudo, M., Chung, H., & Osaki, Y.Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J. Gastroenterol. 2003; 38:207–215.CrossRefGoogle Scholar
Schnater, J. M., Aronson, D. C., Plaschkes, J.et al.Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 2002; 94:1111–1120.CrossRefGoogle ScholarPubMed
Douglass, E. C., Reynolds, M., Finegold, M., Cantor, A. B., & Glicksman, A.Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J. Clin. Oncol. 1993; 11:96–99.CrossRefGoogle ScholarPubMed
Pritchard, J., Brown, J., Shafford, E.et al.Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach – results of the first prospective study of the International Society of Pediatric Oncology. J. Clin. Oncol. 2000; 18:3819–3828.CrossRefGoogle ScholarPubMed
Finegold, M. J.Chemotherapy for suspected hepatoblastoma without effort at surgical resection is bad practice. Med. Pediatr. Oncol. 2002; 39:484–486.CrossRefGoogle Scholar
Ortega, J. A., Krailo, M. D., Haas, J. E.et al.Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J. Clin. Oncol. 1991; 9:2167–2176.CrossRefGoogle ScholarPubMed
Reynolds, M.Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study. World. J. Surg. 1995; 19:814–816.CrossRefGoogle ScholarPubMed
Ehrlich, P. F., Greenberg, M. L., & Filler, R. M.Improved long-term survival with preoperative chemotherapy for hepatoblastoma. J. Pediatr. Surg. 1997; 32:999–1002.CrossRefGoogle ScholarPubMed
Perilongo, G., Shafford, E., Maibach, R.et al.Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology – SIOPEL 2. Eur. J. Cancer 2004; 40:411–421.CrossRefGoogle ScholarPubMed
Fuchs, J., Rydzynski, J., Schweinitz, D.et al.Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 2002; 95:172–182.CrossRefGoogle ScholarPubMed
Stringer, M. D.Liver tumors. Semin. Pediatr. Surg. 2000; 9:196–208.CrossRefGoogle ScholarPubMed
Schweinitz, D., Faundez, A., Teichmann, B.et al.Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma. Int. J. Cancer 2000; 85:151–159.3.0.CO;2-6>CrossRefGoogle Scholar
Czauderna, P., MacKinlay, G., Perilongo, G.et al.Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J. Clin. Oncol. 2002; 20:2798–2804.CrossRefGoogle ScholarPubMed
Schweinitz, D., Burger, D., Bode, U.et al.Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol. Klin. Padiatr. 1994; 206:282–288.CrossRefGoogle Scholar
Schweinitz, D., Fuchs, J., & Mildenberger, H.Surgical strategy in pediatric liver malignancies. Langenbecks Arch. Chir. Suppl Kongressbd. 1996; 113:1091–1094.Google Scholar
Katzenstein, H. M., Krailo, M. D., Malogolowkin, M. H.et al.Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. J. Clin. Oncol. 2002; 20:2789–2797.CrossRefGoogle ScholarPubMed
Bruix, J. & Llovet, J. M.Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35:519–524.CrossRefGoogle ScholarPubMed
Reyes, J. D., Carr, B., Dvorchik, I.et al.Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J. Pediatr. 2000; 136:795–804.CrossRefGoogle ScholarPubMed
Han, Y. M., Park, H. H., Lee, J. M.et al.Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma. J. Vasc. Interv. Radiol. 1999; 10:1275–1280.CrossRefGoogle ScholarPubMed
Malogolowkin, M. H., Stanley, P., Steele, D. A., & Ortega, J. A.Feasibility and toxicity of chemoembolization for children with liver tumors. J. Clin. Oncol. 2000; 18:1279–1284.CrossRefGoogle ScholarPubMed
Arcement, C. M., Towbin, R. B., Meza, M. P.et al.Intrahepatic chemoembolization in unresectable pediatric liver malignancies. Pediatr. Radiol. 2000; 30:779–785.CrossRefGoogle ScholarPubMed
St Peter, S. D., Moss, A. A., Huettl, E. A., Leslie, K. O., & Mulligan, D. C.Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma. Clin. Transpl. 2003; 17:549–553.CrossRefGoogle ScholarPubMed
Tepetes, K., Selby, R., Webb, M., Madariaga, J. R., Iwatsuki, S., & Starzl, T. E.Orthotopic liver transplantation for benign hepatic neoplasms. Arch. Surg. 1995; 130:153–156.CrossRefGoogle ScholarPubMed
Huguet, C., Gavelli, A., Chieco, P. A.et al.Liver ischemia for hepatic resection: where is the limit?Surgery 1992; 111:251–259.Google ScholarPubMed
Pichlmayr, R., Grosse, H., Hauss, J.et al.Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br. J. Surg. 1990; 77:21–26.CrossRefGoogle ScholarPubMed
Pimpalwar, A. P., Sharif, K., Ramani, P.et al.Strategy for hepatoblastoma management: transplant versus nontransplant surgery. J. Pediatr. Surg. 2002; 37:240–245.CrossRefGoogle ScholarPubMed
Srinivasan, P., McCall, J., Pritchard, J.et al.Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation 2002; 74:652–655.CrossRefGoogle ScholarPubMed
Otte, J. B., Pritchard, J., Aronson, D. C.et al.Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr. Blood Cancer 2004; 42:74–83.CrossRefGoogle ScholarPubMed
Dall'Igna, P., Cecchetto, G., Toffolutti, T.et al.Multifocal hepatoblastoma: is there a place for partial hepatectomy?Med. Pediatr. Oncol. 2003; 40:113–116.CrossRefGoogle Scholar
Passmore, S. J., Noblett, H. R., Wisheart, J. D., & Mott, M. G.Prolonged survival following multiple thoracotomies for metastatic hepatoblastoma. Med. Pediatr. Oncol. 1995; 24:58–60.CrossRefGoogle ScholarPubMed
Schweinitz, D., Hecker, H., Harms, D.et al.Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma – a report from the German Cooperative Pediatric Liver Tumor Study HB-89. J. Pediatr. Surg. 1995; 30:845–852.CrossRefGoogle Scholar
Otte, J. B.Is it right to develop living related liver transplantation? Do reduced and split livers not suffice to cover the needs?Transpl. Int. 1995; 8:69–73.CrossRefGoogle Scholar
Dower, N. A., Smith, L. J., Lees, G.et al.Experience with aggressive therapy in three children with unresectable malignant liver tumors. Med. Pediatr. Oncol. 2000; 34:132–135.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
Colombani, P. M., Lau, H., Prabhakaran, K. et al. Cumulative experience with pediatric living related liver transplantation. J. Pediatr. Surg. 2000; 35:9–12.CrossRefGoogle ScholarPubMed
Gehrke, I., Sharif, K., Noujaim, H., Ville, Goyet J., McKiernan, P., & Kelly, D. A.Low-tacrolimus serum through levels combined with Daclizumab induction in paediatric liver transplantation; a pilot study. Pediatr. Transpl. 2003; 7:301–305.Google Scholar
Mazzaferro, V., Regalia, E., Doci, R.et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996; 334:693–699.CrossRefGoogle ScholarPubMed
Yao, F. Y., Ferrell, L., Bass, N. M.et al.Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33:1394–1403.CrossRefGoogle Scholar
Roayaie, S., Frischer, J. S., Emre, S. H.et al.Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann. Surg. 2002; 235:533–539.CrossRefGoogle ScholarPubMed
Madriaga, J. R., Marino, I. R., Karavias, M. A.et al.Long-term results after liver transplantation for primary hepatic Hemangioendothelioma. Ann. Surg. Oncol. 1995; 2:483–487.CrossRefGoogle Scholar
Taege, C., Holzhausen, H. J., Gunter, G.et al.Das Malinge epitheliode haemangioendotheliom der leber. Pathologie 1999; 20:345–350.CrossRefGoogle Scholar
Wheatley, J. M., Rosenfield, N. S., Berger, L., & LaQuaglia, M. P.Liver regeneration in children after major hepatectomy for malignancy – evaluation using a computer-aided technique of volume measurement. J. Surg. Res. 1996; 61:183–189.CrossRefGoogle ScholarPubMed
Chen, J. C., Chen, C. C., Chen, W. J., Lai, H. S., Hung, W. T., & Lee, P. H.Hepatocellular carcinoma in children: clinical review and comparison with adult cases. J. Pediatr. Surg. 1998; 33:1350–1354.CrossRefGoogle ScholarPubMed
Steinherz, L. J., Steinherz, P. G., & Tan, C.Cardiac failure and dysrhythmias 6–19 years after anthracycline therapy: a series of 15 patients. Med. Pediatr. Oncol. 1995; 24:352–361.CrossRefGoogle ScholarPubMed
Green, D. M., Hyland, A., Chung, C. S., Zevon, M. A., & Hall, B. C.Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. J. Clin. Oncol. 1999; 17:3207–3215.CrossRefGoogle ScholarPubMed
McManus, R. P., & O'Hair, D. P.Pediatric heart transplantation for doxorubicin-induced cardiomyopathy. J. Heart Lung Transpl. 1992; 11:375–376.Google ScholarPubMed
Luthy, A., Furrer, M., Waser, M.et al.Orthotopic heart transplantation: an efficient treatment in a young boy with doxorubicin-induced cardiomyopathy. J. Heart Lung Transpl. 1992; 11:815–816.Google Scholar
Dorent, R., Pavie, A., Nataf, P.et al.Heart transplantation is a valid therapeutic option for anthracycline cardiomyopathy. Transpl. Proc. 1995; 27:1683.Google ScholarPubMed
Brock, P. R., Yeomans, E. C., Bellman, S. C., & Pritchard, J.Cisplatin therapy in infants: short and long-term morbidity. Br. J. Cancer Suppl 1992; 18:S36–S40.Google ScholarPubMed
Molmenti, E. P., Wilkinson, K., Molmenti, H.et al.Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am. J. Transpl. 2002; 2:535–538.CrossRefGoogle ScholarPubMed
Sasaki, F., Matsunaga, T., Iwafuchi, M.et al.Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: a report from the Japanese Study Group for Pediatric Liver Tumor. J. Pediatr. Surg. 2002; 37:851–856.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×